The #1 prescribed daily disposable around the world satisfies a broad range of patients

ORDER NOW

To maximize fitting successExplore Fitting Resources

Presbyopia requires more complex vision correction and a demand for precision

Image showing what presbyopia is and how it impacts vision      

Innovative Technology

Introducing a contact lens with an EYE-INSPIRED™ Design that allows you to better address the needs of the presbyopic eye.

INTUISIGHT™ Technology: Pupil Optimization for the presbyopic eye

1-DAY ACUVUE® MOIST Brand MULTIFOCAL is the only multifocal lens that uniquely optimizes the optical design to the pupil size according to age and refractive power for a superior vision experience for more patients.

Pupil optimized designs

The only multifocal contact lens that closely matches the optical design to the pupil size, with 183 unique designs engineered according to age and refractive error (+6.00 to -9.00 in 0.25D steps across three ADD powers*)

Image showing how ACUVUE® multifocal lenses are optimized for pupils

Fixed optical designs

Competitors who use a one-size-fits-all approach that does not address the natural variation in pupil size.

Image showing how competitor contact lenses have fixed optical designs

Precise fit

Unique Hybrid Back Curve gives a precise fit for the presbyopic eye. Centration helps align optical design over the pupil for a superior vision experience for more patients.

Image showing how ACUVUE® contacts are fit for the presbyopic eye      

Proven Platform

1-DAY ACUVUE® MOIST Brand MULTIFOCAL is built on the #1 Daily Disposable ACUVUE® MOIST platform.

Dual Action Technology

1-DAY ACUVUE® MOIST uses unique Dual Action Technology that helps keep moisture in and irritation out.

Safety and health

In a year-long observational study, 1-DAY ACUVUE® MOIST has no serious or infiltrative events. Extremely low incidence of ocular adverse events, with only 3 non-significant contact lens-related events***.

UV blocking

1-DAY ACUVUE® MOIST blocks approximately 97% of UVB and 82% UVA rays.

Why 1-DAY ACUVUE® MOIST MULTIFOCAL?

1-DAY ACUVUE® MOIST MULTIFOCAL offers a superior vision experience for your patients.

94% of patients were successfully fit with two pairs of lenses or less when using Fitting Tips**

Chart showing that 94% of patients were successfully fit with two pairs of contact lenses when using Fitting Tips

High satisfaction among eye care professionals and patients1

In an in-market assessment, after being fit successfully and wearing 1-DAY ACUVUE® MOIST Brand MULTIFOCAL for ~1 week: 
 

 

#1 fit brand of daily disposable multifocal contact lenses in the U.S.2

FITTING RESOURCES

To maximize fitting success, explore our tips, eLearning content and fitting guide below.

Lens Details

ACUVUE® MOIST Brand MULTIFOCAL contact lenses package ACUVUE® MOIST Brand MULTIFOCAL contact lenses package

Parameters

8.4 mm base curve/14.3 mm diameter

SEE MORE

Power ranges

+6.00D to –9.00D (0.25D steps)
  

ADDs

Low (+0.75D to +1.25D)
Mid (+1.50D to +1.75D)
High (+2.00D to +2.50D)
SEE LESS

Wear & replace schedule

Daily disposable

Lens material etafilcon A

Technology LACREON® Technology

Dk *1 28.0

Water content 58%

FDA Classification Group 4

UV blocker Class 2

Center thickness at -3.00D (mm) 0.084

Inside-out mark Yes (1-2-3)

Visibility tint Yes

Package size 30 or 90 lenses

Parameters

8.4 mm base curve/14.3 mm diameter

SEE MORE

Power ranges

+6.00D to –9.00D (0.25D steps)
  

ADDs

Low (+0.75D to +1.25D)
Mid (+1.50D to +1.75D)
High (+2.00D to +2.50D)
SEE LESS

Wear & replace schedule

Daily disposable

Additional 1-DAY ACUVUE® MOIST products

1-DAY ACUVUE® MOIST family provides continuity of care across a broad range of patients.

Ratings & Reviews

 
 

*For illustrative purposes only. Pupil area can vary by ~20% at a given luminance. Across the power range of +4.00D to -6.00D.

**Up to 4 lenses total.

1 In-market assessment with 1-DAY ACUVUE® MOIST Brand MULTIFOCAL, 5 to 10 days daily wear with the new and existing soft contact lens wear. UK: 82 sites and 901 subjects; USA: 152 sites and 1092 subjects. Eye care professional results are based on 168 responses. Patient results are based on responses of 378 patients to a follow-up survey after 1 week of wear.

2 AlphaimpactRx using the ProVoice Survey fielded from May 2015 to April 2016.

UV-blocking percentages are based on average across the wavelength spectrum. Helps protect against transmission of harmful UV radiation to the cornea and into the eye.

Class 2: Must transmit less than 50% of UVA and 5% (<5%) UVB. UV-blocking percentages are based on an average across the wavelength spectrum.

WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.3 Based on in vitro data; clinical studies have not been done directly linking differences in lysozyme profile with specific clinical benefits.

*** Chalmers RL, Hickson-Curran SB, Keay L, Gleason W J, Albright R. Rates of adverse events with hydrogel and silicone hydrogel daily disposable lenses in a large post-market surveillance registry-The TEMPO Registry. Invest Opthamol Vis Sci. 2015. In press.

*1 Units: x 10-11 (cm2/sec) (ml O2 /ml x mm Hg) @35oC Fatt (boundary corrected, non-edge corrected).

 

ACUVUE® Brand Contact Lenses are indicated for vision correction. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. Consult the package insert for complete information. Complete information is also available by visiting acuvueprofessional.com or by calling: In North America: Johnson & Johnson Vision Care, Inc. at 1-800-843-2020.

BACK Close

Login

BACK Close
BACK Close

Link to orderacuvue.com

Access your orderacuvue.com account through MyACUVUE® Pro.

Log in to link your MyACUVUE® Pro to orderacuvue.com.

Don’t have MyACUVUE® Pro? Register.

BACK Close

Would you like to exit the survey without end ?

Quit survey Continue questionnaire
BACK Close

Are you sure you want to cancel your subscription?

You will still be responsible for any fees contracted or accrued on your account, and there are no refunds. You may continue to use your services until your contract end date on [SERVICE END DATE].

How many subscriptions do you want to unsubscribe from?[COMBO LICENSES]

Yes, Cancel No, go back
BACK Close

Why are we replacing UPP?

We are discontinuing UPP in order to renew and continue our commitment to advocate for the doctor-patient relationship and against legislation that threatens to deregulate the industry and undermine patient health.

We introduced UPP in 2014, and today a majority of patients are paying less for their ACUVUE® Brand Contact Lenses than two years ago. Since 2014, there have also been significant legal and legislative challenges to UPP across the country that are distracting our focus on emerging issues that could lead to deregulation of contact lenses. Proponents of deregulation advocate for harmful policies, such as online prescribing of contact lenses and extending contact lens prescription expiration limits. Opposing these efforts requires our undivided attention. 

Our new ACUVUE® Rewards Program replaces UPP and provides similar benefits—affordability, access, and patient retention.